Genomic

Dataset Information

0

GWAS for Genetic Determinants of Bone Fragility


ABSTRACT:

Osteoporotic fractures are largely due to an increased propensity to fall with aging and a reduction in bone strength. Although skeletal architecture contributes to fracture risk, bone mineral density (BMD) is the most important determinant of bone strength and fracture risk. Between 60 and 80% of the variance of BMD of adult Caucasian women is due to heritable factors. Final BMD is a function of peak bone mass attained during young adulthood and the subsequent rate of bone loss, which occurs as a result of both post-menopausal estrogen loss and aging. The evidence for a genetic contribution to rate of loss in BMD is substantially weaker than that for peak BMD. Therefore, we have focused our sample collection on the recruitment of premenopausal women, in whom we have sought to identify the genes influencing peak BMD at the spine and hip, the two major skeletal sites of osteoporotic fracture.

The primary goal of this study is to identify genes that affect peak BMD in premenopausal women. Identification of these genes may: 1) lead to molecular tests that predict risk of osteoporosis and allow institution of early preventive measures; 2) provide insight into basic bone cell biology and other factors that affect peak BMD; and 3) provide molecular targets for therapeutic agents to increase BMD.

PROVIDER: phs000138 | dbGaP |

SECONDARY ACCESSION(S): PRJNA75699PRJNA75697

REPOSITORIES: dbGaP

Similar Datasets

| phs000138.v2.p1 | EGA
2015-09-09 | E-GEOD-72815 | biostudies-arrayexpress
2024-06-20 | GSE253863 | GEO
2024-09-02 | BIOMD0000000612 | BioModels
2020-10-07 | GSE155476 | GEO
2017-06-12 | MSV000081157 | MassIVE
2018-01-22 | GSE98613 | GEO
2022-10-19 | MTBLS3341 | MetaboLights
2007-07-16 | GSE8479 | GEO
2021-06-07 | PXD023578 | Pride